Product Information Management (PIM) Market Share, Size, Trends, Industry Analysis Report, By Deployment Type (On-premises and Cloud); By Organization Size; By Verticals; By Region; Segment Forecast, 2022 - 2030
Description
The global product information management (PIM) market size is expected to reach USD 62.67 billion by 2034, according to a new study by Polaris Market Research. The report “Product Information Management (PIM) Market Share, Size, Trends, Industry Analysis Report, By Deployment (On-premises and Cloud); By Organization Size; By Verticals; By Region; Segment Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising digitization and growing access to consumers for product information management through several sources, coupled with the massive increase in e-commerce sector, are major factors favoring the market growth. Moreover, high adoption of advanced PIM solutions across various industries such as retail, banking, healthcare, transportation, and financial services around the globe is further anticipated to propel the growth and demand for the global market over the coming years.
For instance, as per the report published by Flipkart and Bain., the total number of online shoppers in India is projected to grow to around 400 to 450 million by 2027. The Indian e-retail market is estimated to grow by around 25-30% annually over the coming years.
Continuously rising investments in automation to enable quicker decisions, along with ever-rising competition and high business growth, around the globe to facilitate business operations, equipment, data management, and types of machinery is likely to have a positive impact on the global market at a healthy growth rate in the coming years.
In May 2022, Pimcore, a leading service provider in PIM solutions market introduced their new and more enhanced Pimcore 10.4 with high importance on consumer experience, API improvements, optimizations, and security. With the help of company’s new offering, organizations will be able to preview data or product information from any of their device like laptop, mobile, and tablets.
Product Information Management (PIM) Market Report Highlights
On-premises segment held the largest market share in 2024 owing to high adoption among various industries, including banking, healthcare, retail, insurance, and life sciences.
Large enterprises segment accounted for major revenue share due to the rising investment in research & development activities and heavy funding in novel technology.
Retail sector is expected to hold a significant market share over the forecast period due to the rising prevalence of the e-commerce industry coupled with the enhancing customer experience and adoption of artificial intelligence.
Asia Pacific region is expected to grow at a high CAGR during the projected period because of the increasing consumer awareness regarding the latest technology development and the rising popularity of online shopping in the region.
The global PIM market is fairly fragmented owing to the presence of large market players with global presence including IBM Corporation, Oracle Corporation, Salsify Inc., Akeneo, Stibo Systems and others.
Polaris Market Research has segmented the product information management (PIM) market report based on deployment, organization size, verticals, and region:
Product Information Management (PIM), Deployment Outlook (Revenue - USD Billion, 2020 - 2034)
On-premise
Cloud
Product Information Management (PIM), Organization Size Outlook (Revenue - USD Billion, 2020 - 2034)
Large Enterprise
Small Enterprise
Product Information Management (PIM), Verticals Outlook (Revenue - USD Billion, 2020 - 2034)
Banking and Financial Services
Manufacturing
Retail
IT & Telecom
Transportation & Logistics
Others
Product Information Management (PIM), Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
The rising digitization and growing access to consumers for product information management through several sources, coupled with the massive increase in e-commerce sector, are major factors favoring the market growth. Moreover, high adoption of advanced PIM solutions across various industries such as retail, banking, healthcare, transportation, and financial services around the globe is further anticipated to propel the growth and demand for the global market over the coming years.
For instance, as per the report published by Flipkart and Bain., the total number of online shoppers in India is projected to grow to around 400 to 450 million by 2027. The Indian e-retail market is estimated to grow by around 25-30% annually over the coming years.
Continuously rising investments in automation to enable quicker decisions, along with ever-rising competition and high business growth, around the globe to facilitate business operations, equipment, data management, and types of machinery is likely to have a positive impact on the global market at a healthy growth rate in the coming years.
In May 2022, Pimcore, a leading service provider in PIM solutions market introduced their new and more enhanced Pimcore 10.4 with high importance on consumer experience, API improvements, optimizations, and security. With the help of company’s new offering, organizations will be able to preview data or product information from any of their device like laptop, mobile, and tablets.
Product Information Management (PIM) Market Report Highlights
On-premises segment held the largest market share in 2024 owing to high adoption among various industries, including banking, healthcare, retail, insurance, and life sciences.
Large enterprises segment accounted for major revenue share due to the rising investment in research & development activities and heavy funding in novel technology.
Retail sector is expected to hold a significant market share over the forecast period due to the rising prevalence of the e-commerce industry coupled with the enhancing customer experience and adoption of artificial intelligence.
Asia Pacific region is expected to grow at a high CAGR during the projected period because of the increasing consumer awareness regarding the latest technology development and the rising popularity of online shopping in the region.
The global PIM market is fairly fragmented owing to the presence of large market players with global presence including IBM Corporation, Oracle Corporation, Salsify Inc., Akeneo, Stibo Systems and others.
Polaris Market Research has segmented the product information management (PIM) market report based on deployment, organization size, verticals, and region:
Product Information Management (PIM), Deployment Outlook (Revenue - USD Billion, 2020 - 2034)
On-premise
Cloud
Product Information Management (PIM), Organization Size Outlook (Revenue - USD Billion, 2020 - 2034)
Large Enterprise
Small Enterprise
Product Information Management (PIM), Verticals Outlook (Revenue - USD Billion, 2020 - 2034)
Banking and Financial Services
Manufacturing
Retail
IT & Telecom
Transportation & Logistics
Others
Product Information Management (PIM), Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
117 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Cell and Gene Therapy Clinical Trials Market Insights
- 4.1. Cell and Gene Therapy Clinical Trials Market – Market Snapshot
- 4.2. Cell and Gene Therapy Clinical Trials Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. High Prevalence of Rare and Genetic Disorders
- 4.2.1.2. Rising R&D Investment in Advanced Therapies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Initial Investment
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Cell and Gene Therapy Clinical Trials Market Indication Trends
- 4.6. Value Chain Analysis
- 5. Global Cell and Gene Therapy Clinical Trials Market, by Phase
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 5.3. Phase I
- 5.3.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase I, by Region, 2020-2034 (USD Billion)
- 5.4. Phase II
- 5.4.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase II, by Region, 2020-2034 (USD Billion)
- 5.5. Phase III
- 5.5.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase III, by Region, 2020-2034 (USD Billion)
- 5.6. Phase IV
- 5.6.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase IV, by Region, 2020-2034 (USD Billion)
- 6. Global Cell and Gene Therapy Clinical Trials Market, by Indication
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 6.3. Oncology
- 6.3.1. Global Cell and Gene Therapy Clinical Trials Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 6.4. Cardiology
- 6.4.1. Global Cell and Gene Therapy Clinical Trials Market, by Cardiology, by Region, 2020-2034 (USD Billion)
- 6.5. CNS
- 6.5.1. Global Cell and Gene Therapy Clinical Trials Market, by CNS, by Region, 2020-2034 (USD Billion)
- 6.6. Musculoskeletal
- 6.6.1. Global Cell and Gene Therapy Clinical Trials Market, by Musculoskeletal, by Region, 2020-2034 (USD Billion)
- 6.7. Infectious diseases
- 6.7.1. Global Cell and Gene Therapy Clinical Trials Market, by Infectious diseases, by Region, 2020-2034 (USD Billion)
- 6.8. Dermatology
- 6.8.1. Global Cell and Gene Therapy Clinical Trials Market, by Dermatology, by Region, 2020-2034 (USD Billion)
- 6.9. Endocrine, metabolic, genetic
- 6.9.1. Global Cell and Gene Therapy Clinical Trials Market, by Endocrine, metabolic, genetic, by Region, 2020-2034 (USD Billion)
- 6.10. Immunology & inflammation
- 6.10.1. Global Cell and Gene Therapy Clinical Trials Market, by Immunology & inflammation, by Region, 2020-2034 (USD Billion)
- 6.11. Ophthalmology
- 6.11.1. Global Cell and Gene Therapy Clinical Trials Market, by Ophthalmology, by Region, 2020-2034 (USD Billion)
- 6.12. Hematology
- 6.12.1. Global Cell and Gene Therapy Clinical Trials Market, by Hematology, by Region, 2020-2034 (USD Billion)
- 6.13. Gastroenterology
- 6.13.1. Global Cell and Gene Therapy Clinical Trials Market, by Gastroenterology, by Region, 2020-2034 (USD Billion)
- 6.14. Others
- 6.14.1. Global Cell and Gene Therapy Clinical Trials Market, by Others, by Region, 2020-2034 (USD Billion)
- 7. Global Cell and Gene Therapy Clinical Trials Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Cell and Gene Therapy Clinical Trials Market Assessment, By Geography, 2020-2034 (USD Billion)
- 7.3. Cell and Gene Therapy Clinical Trials Market – North America
- 7.3.1. North America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.3.2. North America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.3.3. Cell and Gene Therapy Clinical Trials Market – U.S.
- 7.3.3.1. U.S.: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.3.3.2. U.S.: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.3.4. Cell and Gene Therapy Clinical Trials Market – Canada
- 7.3.4.1. Canada: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.3.4.2. Canada: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.3.5. Cell and Gene Therapy Clinical Trials Market – Mexico
- 7.3.5.1. Mexico: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.3.5.2. Mexico: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.4. Cell and Gene Therapy Clinical Trials Market – Europe
- 7.4.1. Europe: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.4.2. Europe: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.4.3. Cell and Gene Therapy Clinical Trials Market – UK
- 7.4.3.1. UK: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.4.3.2. UK: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.4.4. Cell and Gene Therapy Clinical Trials Market – France
- 7.4.4.1. France: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.4.4.2. France: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.4.5. Cell and Gene Therapy Clinical Trials Market – Germany
- 7.4.5.1. Germany: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.4.5.2. Germany: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.4.6. Cell and Gene Therapy Clinical Trials Market – Italy
- 7.4.6.1. Italy: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.4.6.2. Italy: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.4.7. Cell and Gene Therapy Clinical Trials Market – Spain
- 7.4.7.1. Spain: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.4.7.2. Spain: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.4.8. Cell and Gene Therapy Clinical Trials Market – Netherlands
- 7.4.8.1. Netherlands: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.4.8.2. Netherlands: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.4.9. Cell and Gene Therapy Clinical Trials Market – Russia
- 7.4.9.1. Russia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.4.9.2. Russia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.4.10. Cell and Gene Therapy Clinical Trials Market – Rest of Europe
- 7.4.10.1. Rest of Europe: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.4.10.2. Rest of Europe: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.5. Cell and Gene Therapy Clinical Trials Market – Asia Pacific
- 7.5.1. Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.5.3. Cell and Gene Therapy Clinical Trials Market – China
- 7.5.3.1. China: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.5.3.2. China: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.5.4. Cell and Gene Therapy Clinical Trials Market – India
- 7.5.4.1. India: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.5.4.2. India: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.5.5. Cell and Gene Therapy Clinical Trials Market – Malaysia
- 7.5.5.1. Malaysia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.5.5.2. Malaysia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.5.6. Cell and Gene Therapy Clinical Trials Market – Japan
- 7.5.6.1. Japan: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.5.6.2. Japan: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.5.7. Cell and Gene Therapy Clinical Trials Market – Indonesia
- 7.5.7.1. Indonesia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.5.7.2. Indonesia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.5.8. Cell and Gene Therapy Clinical Trials Market – South Korea
- 7.5.8.1. South Korea: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.5.8.2. South Korea: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.5.9. Cell and Gene Therapy Clinical Trials Market – Australia
- 7.5.9.1. Australia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.5.9.2. Australia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.5.10. Cell and Gene Therapy Clinical Trials Market – Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.5.10.2. Rest of Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.6. Cell and Gene Therapy Clinical Trials Market – Middle East & Africa
- 7.6.1. Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.6.3. Cell and Gene Therapy Clinical Trials Market – Saudi Arabia
- 7.6.3.1. Saudi Arabia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.6.3.2. Saudi Arabia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.6.4. Cell and Gene Therapy Clinical Trials Market – UAE
- 7.6.4.1. UAE: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.6.4.2. UAE: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.6.5. Cell and Gene Therapy Clinical Trials Market – Israel
- 7.6.5.1. Israel: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.6.5.2. Israel: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.6.6. Cell and Gene Therapy Clinical Trials Market – South Africa
- 7.6.6.1. South Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.6.6.2. South Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.6.7. Cell and Gene Therapy Clinical Trials Market – Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.6.7.2. Rest of Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.7. Cell and Gene Therapy Clinical Trials Market – Latin America
- 7.7.1. Latin America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.7.3. Cell and Gene Therapy Clinical Trials Market – Brazil
- 7.7.3.1. Brazil: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.7.3.2. Brazil: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.7.4. Cell and Gene Therapy Clinical Trials Market – Argentina
- 7.7.4.1. Argentina: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.7.4.2. Argentina: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.7.5. Cell and Gene Therapy Clinical Trials Market – Rest of Latin America
- 7.7.5.1. Rest of Latin America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 7.7.5.2. Rest of Latin America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. Charles River Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. ICON Plc
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. IQVIA
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. LabCorp
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Medpace
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Novotech
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. PAREXEL International Corp.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Syneos Health
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Thermo Fisher Scientific, Inc.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Veristat, LLC
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.